Chronic Insomnia Linked to Accelerated Brain Aging and Cognitive Decline

Chronic insomnia is associated with faster cognitive decline and brain aging, increasing the risk of dementia. New research highlights the importance of sleep health for maintaining cognitive resilience in older adults.
Recent research published in Neurology reveals that individuals suffering from chronic insomnia may experience faster cognitive decline and brain changes associated with aging. The study emphasizes that insomnia, characterized by difficulty sleeping at least three nights a week for three months or longer, is associated with a 40% increased risk of developing mild cognitive impairment or dementia. This translates to approximately 3.5 years of additional brain aging.
The investigation monitored 2,750 cognitively healthy older adults with an average age of 70 over around 5.6 years. Participants reported their sleep patterns over the past two weeks, and underwent yearly memory and thinking assessments, as well as brain imaging scans. These scans looked for white matter hyperintensities—markers of small vessel disease—and amyloid plaques, proteins linked to Alzheimer’s disease.
Findings indicated that those with chronic insomnia had a higher likelihood of developing cognitive issues, with 14% progressing to mild cognitive impairment or dementia, compared to 10% in those without sleep difficulties. Even after adjusting for factors like age, high blood pressure, sleep medication use, and sleep apnea, insomnia was still associated with a 40% increased risk.
Interestingly, the study noted differences based on sleep changes: individuals sleeping less than usual in the recent two weeks showed more significant brain changes and lower baseline cognitive scores, comparable to four years of aging. They also had increased white matter hyperintensities and amyloid deposition, effects somewhat similar to the presence of the APOE ε4 gene, a known genetic risk factor for Alzheimer’s.
Conversely, those sleeping more than usual generally exhibited fewer white matter hyperintensities at the study's start. The research highlights that sleep disturbances may impact the brain via different mechanisms, involving not only amyloid accumulation but also small vessel health. The author, Dr. Diego Z. Carvalho of the Mayo Clinic, stresses the importance of treating chronic insomnia, suggesting that improving sleep could help protect brain health over time.
Limitations include reliance on medical records for insomnia diagnosis, which may miss undiagnosed cases or symptom severity. Despite this, the evidence underscores sleep's critical role in maintaining cognitive resilience as we age.
This study adds to growing awareness that healthy sleep is vital for brain health and could be a modifiable factor in preventing or delaying neurodegenerative diseases.
Source: https://medicalxpress.com/news/2025-09-insomniacs-brain-aging.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Proximity to Golf Courses Associated with Increased Parkinson's Disease Risk
A recent study reveals a significant association between living near golf courses and an increased risk of Parkinson's disease, especially in regions with groundwater vulnerability due to pesticide use. This research emphasizes environmental factors' role in neurodegenerative diseases and urges protective measures for affected communities.
Brain Activity Patterns Distinguish Autistic Teens Who Mask Socially
New research reveals how brain activity differs in autistic teens who mask their diagnosis, with faster responses to faces and reduced emotional reactivity—offering insights into the mental effort behind social masking.
Over 1 Million People May Avoid Trump's Medicaid Work Rules in Areas with High Unemployment
A new analysis suggests that over a million Medicaid enrollees in high-unemployment areas could avoid federal work requirements, providing relief to those facing job scarcity while maintaining healthcare coverage.
Targeting Enzyme Activity Offers Hope for Parkinson's Disease Treatment
Innovative research reveals that inhibiting the overactive enzyme LRRK2 can protect neurons and potentially reverse early Parkinson's disease cellular damage, offering new hope for treatment.



